Approval · Notice of Compliance 24758 · 2020
INVANZ: Notice of Compliance 24758
Issued December 8, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24758
- Date
- December 8, 2020
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add standard safety warnings to the product monograph regarding beta-lactam antibiotics and the risk of severe skin side effects (severe cutaneous adverse reactions, scar)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INVANZ | Not yet assigned | — |
Medicinal ingredients
- ERTAPENEM SODIUM 1 G per VIAL